BRAF and melanoma: In this respect, VEGF-dependent neuropilin signaling has been reported to play a relevant role in cancer; however, we have previously shown that VEGF is unlikely to be implicated in establishing NRP1-dependent melanoma resistance to BRAF inhibitors [7].